Showing results (1-10 of 32,806) with videos related to
Sort By:
Pageof 3,281
Expert Opinion on Therapeutic Targets|October 15, 2010
Targeting miR-21 in glioma: a small RNA with big potentialLynette M Moore, Wei ZhangChinese Journal of Cancer|March 1, 2011
Oncogene interactions are required for glioma development and progression as revealed by a tissue specific transgenic mouse modelLynette M Moore, Kristen M Holmes, Gregory N Fuller, et al.Neuro-Oncology|July 24, 2013
IDH1/2 mutations target a key hallmark of cancer by deregulating cellular metabolism in gliomaChunzhi Zhang, Lynette M Moore, Xia Li, et al.Proceedings of the National Academy of Sciences of the United States of America|October 7, 2009
IGFBP2 is a candidate biomarker for Ink4a-Arf status and a therapeutic target for high-grade gliomasLynette M Moore, Kristen M Holmes, Sarah M Smith, et al.The Journal of Pathology|September 26, 2012
Transcriptome and small RNA deep sequencing reveals deregulation of miRNA biogenesis in human gliomaLynette M Moore, Virpi Kivinen, Yuexin Liu, et al.Proceedings of the National Academy of Sciences of the United States of America|February 21, 2012
Insulin-like growth factor-binding protein 2-driven glioma progression is prevented by blocking a clinically significant integrin, integrin-linked kinase, and NF-κB networkKristen M Holmes, Matti Annala, Corrine Y X Chua, et al.Oncogene|April 22, 2014
Two mature products of MIR-491 coordinate to suppress key cancer hallmarks in glioblastomaXia Li, Yuexin Liu, Kirsi J Granberg, et al.Progress in Biophysics and Molecular Biology|August 24, 2006
Rapporteur report: EpidemiologyWei ZhangHistory of Psychology|August 28, 2025
Teaching history of psychotherapy to undergraduates: An interview with Elizabeth LunbeckWei ZhangPageof 3,281